KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) Operating Income (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Operating Income for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Operating Income rose 148.52% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$16.6 million through Dec 2025, down 270.85% year-over-year, with the annual reading at -$16.6 million for FY2025, 270.83% down from the prior year.
  • Operating Income for Q4 2025 was $1.3 million at Biolife Solutions, up from -$89000.0 in the prior quarter.
  • The five-year high for Operating Income was $90.3 million in Q4 2022, with the low at -$76.6 million in Q2 2022.
  • Average Operating Income over 5 years is -$4.2 million, with a median of -$3.9 million recorded in 2021.
  • The sharpest move saw Operating Income crashed 10452.27% in 2021, then soared 589.29% in 2022.
  • Over 5 years, Operating Income stood at -$18.5 million in 2021, then skyrocketed by 589.29% to $90.3 million in 2022, then tumbled by 80.6% to $17.5 million in 2023, then crashed by 96.91% to $542000.0 in 2024, then skyrocketed by 148.52% to $1.3 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at $1.3 million, -$89000.0, and -$16.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.